Susie Adams, PhD, RN, PMHNP, FAANP, FAAN
Professor of Nursing
Immediate Past-President, American Psychiatric Nurses Association
Faculty Scholar for Community Engaged Behavioral Health
Vanderbilt University School of Nursing
1.0 contact hour of continuing education (which includes 0.50 hour of pharmacology)
Major depressive disorder (MDD) is one of the most common mental disorders diagnosed in the United States, with an estimated 16% of US adults experiencing MDD at some point during their lifetimes. According to the American Medical Association, chronic depression is often untreated and, on average, patients with depression receive the recommended quality of care only 58% of the time. The goal of this activity is to expand knowledge, skills, and competency among nurse practitioners (NPs) in diagnosing and selecting optimal individualized therapy for adults with MDD, ultimately helping to achieve the best possible patient outcomes.
Developed by the American Association of Nurse Practitioners in cooperation with
This program was developed for nurse practitioners.
Upon completion of this educational activity, the participant should be able to:
- Summarize guideline changes in the new Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, that impact the diagnosis and assessment of MDD.
- Assess the severity and risks of depression at the time of diagnosis.
- Summarize current evidence for efficacy and safety of new therapies recently approved for the treatment of depression.
- Develop customized treatment regimens for adults with depression, considering medication efficacy and safety, drug interactions, dosing options, and patient comorbidities.
- Explain the benefits of using rating scales to assess patient response to depression treatment and medication side effects.
Dr. Adams has no conflicts of interest to disclose.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
This activity is approved for 1.0 contact hour of continuing education (which includes 0.50 hour of pharmacology) by the American Association of Nurse Practitioners. Program ID 16052200.
This activity was planned in accordance with AANP Accreditation Standards and Policies.
Commercial Support Statements
This program is supported through an educational grant from Actavis.
COMPLETING THE POST TEST AND EVALUATION:
- When you return to the AANP CE Center, log in and find the program you wish to complete. On the programís content page you can go directly to Start Post-Test at the bottom of the page. When you have successfully completed the online post-test you will be instructed to complete the online evaluation and then receive your certificate.
- If you do not have a registration (email and password) with AANP, you will be asked to register: MyAANP. Complete the short profile and create your password to continue in the CE Center. Please contact Stormy Causey, CE Coordinator, at CECenter@aanp.org with any questions.
The opinions expressed in this presentation are those of the speaker and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, the American Association of Nurse Practitioners, or Actavis.